Vir Biotechnology (VIR)
(Delayed Data from NSDQ)
$9.54 USD
-0.39 (-3.93%)
Updated May 8, 2024 04:00 PM ET
After-Market: $9.55 +0.01 (0.10%) 6:30 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.93 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | 51.52% |
ABR | 1.78 |
Earnings ESP
|
-0.38% |
---|---|
Current Year | -3.47 |
Next Year | -3.74 |
EPS (TTM) | -4.01 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.57M | 12.61M | 81.02M | 65.06M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 21.30M | 21.40M | 121.80M | 106.20M |
Low Estimate | 5.17M | 5.17M | 56.40M | 21.13M |
Year ago Sales | 3.80M | 2.64M | 86.18M | 81.02M |
Year over Year Growth Est. | 230.87% | 377.50% | -5.99% | -19.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.93 | -0.96 | -3.47 | -3.74 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | -1.08 | -1.11 | -4.19 | -3.81 |
High Estimate | -0.86 | -0.83 | -3.01 | -3.12 |
Low Estimate | -1.10 | -1.16 | -4.03 | -4.65 |
Year ago EPS | -1.45 | -1.22 | -4.59 | -3.47 |
Year over Year Growth Est. | 35.86% | 21.31% | 24.40% | -7.93% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 3 | 5 | 4 |
Up Last 30 Days | 3 | 3 | 5 | 4 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.93 | -0.96 | -3.47 | -3.74 |
7 Days Ago | -1.03 | -1.04 | -4.04 | -3.87 |
30 Days Ago | -1.03 | -1.04 | -4.04 | -3.87 |
60 Days Ago | -1.03 | -1.04 | -4.04 | -3.87 |
90 Days Ago | -1.26 | -1.28 | -4.69 | -4.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.94 | -0.97 | -3.48 | -3.87 |
Zacks Consensus Estimate | -0.93 | -0.96 | -3.47 | -3.74 |
Earnings ESP | -0.38% | -0.70% | -0.22% | -3.33% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.86 | -1.22 | -1.45 | NA |
Estimate | -0.99 | -1.14 | -1.21 | -1.21 | NA |
Difference | 0.51 | 0.28 | -0.01 | -0.24 | 0.14 |
Surprise | 51.52% | 24.56% | -0.83% | -19.83% | 13.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more